| ARCT latest price $47.1800 (-5.47%) ($42.9800 - $51.4500) on Wed. Jan. 21, 2015. |
|
|
| Trend Analysis and Forecast |
| |
Average Daily Percentage Swing | 6.76% (three month average) |
RSI | 89 |
Latest Price | $47.1800(-5.47%) |
Stocks Behave Similarly | Similar Stock List |
Daily Trend | ARCT advances 2.1% a day on average for past five trading days. |
Weekly Trend | ARCT advances 33.3% a week on average for past two weeks. |
Market Behavior | Value stock rally for large cap. Normal for small cap. |
Correlated ETFs | Broad market will support ARCT advance at 0% a week (0% probability) IBB(6%) XBI(5%) XLV(5%) IWM(3%) XHB(3%) |
Factors Impacting ARCT price | ARCT will decline at least -3.38% in a week (0% probabilities). VIXM(-5%) LQD(-5%) GLD(-3%) CEMB(-3%) BND(-3%) |
Explanation | The rally is not sustainable and not supported by the broad market. |
| |
| |
Relative Volatility | (options are extremely cheap) |
| |
Market Trend Strength | -3.38% (StdDev 6.76%) |
Hourly BBV | 0 () |
Intraday Trend | -5.6% |
| |
|
|
July 7, 2020 ARCT develops mRNA based covid vaccine. Now it's still in preclinical stage, and plan to start phase I clinic trail this summer.